Lantheus Medical Imaging

Lantheus is a global leader in the field of medical imaging. We develop, manufacture and commercialize essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care. Our pioneering products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography, nuclear imaging and magnetic resonance imaging (MRI) technologies.

Our products are routinely used to diagnose coronary artery disease (CAD), congestive heart failure (CHF), stroke, peripheral vascular (PVD) and other diseases.

In addition to our diversified portfolio of commercialized imaging agents and products, we have a strong development pipeline of internally-discovered next generation, first-in-class imaging agents that use positron emission tomography (PET), MRI technologies focused on enhancing current imaging modalities and fulfilling unmet diagnostic medical imaging needs.

Billerica, US
Size (employees)
465 (est)-1%
Lantheus Medical Imaging was founded in 1956 and is headquartered in Billerica, US

Lantheus Medical Imaging Office Locations

Lantheus Medical Imaging has offices in Billerica, Montréal
Billerica, US
Montréal, CA

Lantheus Medical Imaging Metrics

Lantheus Medical Imaging Summary

Market capitalization

$443.9 m

Closing share price

Lantheus Medical Imaging's current market capitalization is $443.9 m.

Lantheus Medical Imaging Financials

Lantheus Medical Imaging's revenue is $283.7 m in FY, 2013 which is a 5.9% decrease from the previous period.
FY, 2013FY, 2014


$283.7 m$301.6 m

Revenue growth, %


Net Income

($61.7 m)($1.2 m)

Lantheus Medical Imaging Market Value History

Lantheus Medical Imaging Company Life

You may also be interested in